Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Keysight Technologies | KEYS | Apr 26, 2024 | 148.55 | +0.76 |
Kezar Life Sciences | KZR | Apr 26, 2024 | 0.80 | +1.89 |
KFA Global Carbon ETF | KRBN | Apr 26, 2024 | 32.21 | -0.68 |
Kforce | KFRC | Apr 26, 2024 | 64.13 | +0.20 |
Kidpik | PIK | Apr 26, 2024 | 4.19 | -0.24 |
Kilroy Realty | KRC | Apr 26, 2024 | 33.14 | -0.27 |
Kimball Electronics | KE | Apr 26, 2024 | 20.82 | +0.10 |
Kimbell Royalty Partners LP Units | KRP | Apr 26, 2024 | 16.13 | +0.56 |
Kimberly-Clark | KMB | Apr 26, 2024 | 135.24 | -0.87 |
Kimco Realty | KIM | Apr 26, 2024 | 18.38 | -0.22 |
Kimco Realty L Pref | KIM-L | Apr 26, 2024 | 21.82 | +0.09 |
Kimco Realty M Pref | KIM-M | Apr 26, 2024 | 22.47 | +0.22 |
Kimco Realty Pref ADR | KIM-N | Apr 26, 2024 | 54.70 | 0.00 |
Kinder Morgan | KMI | Apr 26, 2024 | 18.68 | -0.64 |
Kineta | KA | Apr 26, 2024 | 0.61 | -4.66 |
Kinetik A | KNTK | Apr 26, 2024 | 39.03 | -0.43 |
Kingsoft Cloud ADR | KC | Apr 26, 2024 | 3.16 | +10.10 |
Kingstone Companies | KINS | Apr 26, 2024 | 4.40 | +9.18 |
Kingsway Financial Services | KFS | Apr 26, 2024 | 8.58 | +0.59 |
Kiniksa Pharmaceuticals A | KNSA | Apr 26, 2024 | 17.88 | +1.53 |
Kinnate Biopharma | KNTE | Apr 26, 2024 | 2.65 | 0.00 |
Kinross Gold | KGC | Apr 26, 2024 | 6.74 | +0.15 |
Kinsale Capital Group | KNSL | Apr 26, 2024 | 374.64 | -17.31 |
Kintara Therapeutics | KTRA | Apr 26, 2024 | 0.15 | -5.82 |
Kiora Pharmaceuticals | KPRX | Apr 26, 2024 | 0.47 | -2.08 |
Kirby | KEX | Apr 26, 2024 | 112.00 | -0.14 |
Kirklands | KIRK | Apr 26, 2024 | 1.94 | -0.51 |
Kite Realty Group Trust | KRG | Apr 26, 2024 | 21.26 | -0.65 |
KKR & Co | KKR | Apr 26, 2024 | 95.54 | +0.71 |
KKR Income Opportunities Fund | KIO | Apr 26, 2024 | 13.32 | +0.83 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.